ARCHIVES

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Top Officials Resign From San Antonio’s Institute for Drug Development.

January 26, 2007

Five Contracts Funded Under Unconventional Innovations Program

October 22, 1999

Letters to the Editor: Love on Mammography; Freireich, Holland On Bernard Fisher

April 15, 1994

In Brief: Hendrix To Head Children’s Memorial Institute

June 20, 2003

Fox Chase Joins Plan For Free Cancer Screening

May 9, 1986

Congressional Appropriations Committee Leaders Blast White Plans To Slash NIH FY 1987 Budget

February 20, 1987